Upload
joy-gibbs
View
216
Download
0
Embed Size (px)
Citation preview
Epidemiology and Pathophysiology of
Intracerebral Hemorrhage
1 Edward C. Jauch, MD MS FACEP
Edward C. Jauch, MD MS FACEP
Assistant ProfessorAssociate Director of Research
Department of Emergency MedicineUniversity of Cincinnati College of Medicine
Faculty, Greater Cincinnati / Northern Kentucky Stroke Team
2
Edward C. Jauch, MD MS FACEP3
Global ObjectivesGlobal Objectives
• Review epidemiology of ICH
• Understand pathophysiology of ICH
• Discuss lessons from acute ischemic stroke
• Improve Emergency Medicine practice
Edward C. Jauch, MD MS FACEP4
A Clinical CaseA Clinical Case
Edward C. Jauch, MD MS FACEP5
Patient Initial Clinical HistoryPatient Initial Clinical History
• 57 yo male with sudden onset headache and left sided weakness
• Family calls 911
• EMS transport to OLFH Hospital
• Enroute patients symptoms progress to full hemiplegia
• Initial VS: 210 / 120 mmHg, HR 110, R 24
Edward C. Jauch, MD MS FACEP6
Patient ED PresentationPatient ED Presentation• PMHX: HTN for 10 years,
hyperlipidemia
• SHX: Smoking 30 years
• Meds: ACE inhibitor, ASA
• ROS: No recent illness or injuries, no new medications
Edward C. Jauch, MD MS FACEP7
Patient ED PresentationPatient ED Presentation• Physical examination:
• VS - 220 / 140 mmHg, HR 110, RR 22, T 98.6oC• Uncomfortable WM, arouses to voice• HEENT/CV/Lungs/Abd - WNL• Neuro –
• LOC mildly depressed• CN with L facial droop and partial gaze palsy, VFI• Motor with dense L hemiplegia• Sensory with mild L sensory loss• Speech slurred but no significant aphasia• NIHSS = 12
Edward C. Jauch, MD MS FACEP8
Key QuestionsKey Questions• What is your differential diagnosis?
• What are the most common ICH etiologies?
• What is the pathophysiology of ICH?
• What guidelines exist that govern the acute care of ICH patients?
• What can be learned regarding ICH management from acute ischemic stroke?
• How can the emergent care of ICH patients be enhanced?
Edward C. Jauch, MD MS FACEP9
Patient ED PresentationPatient ED Presentation
• Initial noncontrast CT scan
• Labs:– CBC, chem 7 – WNL
– PT, PTT – WNL
– ECG – LVH with strain
Edward C. Jauch, MD MS FACEP10
Stroke SubtypesStroke Subtypes
(NINCDS Stroke Data Bank: Foulkes, Stroke, 1988)
ICH13%
SAH13%
Lacunar19% Thromboembolic
6%
Cardioembolic14%
Other 3%
Unknown32%
Ischemic 71%
Hemorrhagic 26%
Up to 65,000 ICH per year in U.S.Up to 65,000 ICH per year in U.S.
Edward C. Jauch, MD MS FACEP11
ICH ClassificationsICH Classifications
• Primary– Hypertensive arteriopathies– Cerebral amyloid angiopathies
• Secondary– Neoplasms– Structural lesions – Anticoagulants or thrombolytic agents– Drugs (cocaine, ephedra, etc)– Traumatic brain injury
Edward C. Jauch, MD MS FACEP12
LocationLocation• Lobar
– Associated with amyloid angiopathy
• Nonlobar– Associated with hypertension
• Cerebellar• Intraventricular
Edward C. Jauch, MD MS FACEP13
Lobar HemorrhageLobar Hemorrhage
• Secondary to cerebral amyloid angiopathy– Beta-amyloid deposition in
vessels of cortex and leptomeninges
– Associated with aging
• Lobar hemorrhage in young due to AVM, cavernous hemangioma
Edward C. Jauch, MD MS FACEP14
Non-lobar HemorrhageNon-lobar Hemorrhage
• Non-lobar or hypertensive hemorrhage– Associated with hypertensive
arteriolosclerosis
• Location – putamen, pons, thalamus, cerebellum
• Mortality– 50% 30 day mortality
• Exam:– sudden HA with focal findings on exam
Edward C. Jauch, MD MS FACEP15
Risk FactorsRisk Factors
• Age
• Gender (men > women)
• Race (blacks > whites)
• Prior stroke
• Hypertension
• Anticoagulant / thrombolytics
• Alcohol / cocaine19 yo with ephedra 19 yo with ephedra
induced ICHinduced ICH
Edward C. Jauch, MD MS FACEP16
Less Common Risk FactorsLess Common Risk Factors
• Vascular malformations– Arteriovenous malformations (AVM)– Cavernous angiomas– Intracranial aneurysms
• Infections– Cerebral vasculitis– Mycotic aneurysms
• Cerebral venous thrombosis
Edward C. Jauch, MD MS FACEP17
ICH Rate by AgeICH Rate by Age
0
50
100
150
200
250
0-35 35-44 45-54 55-64 65-74 75-84 85+
Rate per 100,000 / year
Age (years)
Edward C. Jauch, MD MS FACEP18
Systolic Blood Pressure & Systolic Blood Pressure & IncidenceIncidence
0
50
100
150
200
250
<110 110-139 140-179 180+
Incidence Rate/100,000
Systolic Blood Pressure (mmHg)
Edward C. Jauch, MD MS FACEP19
Ethnicity of ICH RiskEthnicity of ICH Risk
• Age and sex adjusted rate– U.S. 15 per 100,000
– World wide 10-20 per 100,000
– Higher in African American and Japanese
• Rates 13.5 per 100,000 Caucasian38 per 100,000 AA55 per 100,000 Japanese
Edward C. Jauch, MD MS FACEP20
Anticoagulation and Thrombolytic Anticoagulation and Thrombolytic Related HemorrhageRelated Hemorrhage
• Warfarin anticoagulation– 6-11 fold increased risk of ICH– Higher levels with increased risk– Most occur in therapeutic range
• Thrombolysis and Symptomatic ICH– 6.4% in thrombolysis treatment group
• tPA related hemorrhages typically lobar• 20% occur outside area of infarct
– 0.6% in placebo group
Edward C. Jauch, MD MS FACEP21
Mortality and MorbidityMortality and Morbidity
• Estimated lifetime cost $123,565
• Of the 37,000-65,000 ICH per year
– 35-52% were dead at 1 month
– 50% of deaths occurred within 48 hours
– 10% independent at 30 days
– 20% independent at 6 months
Edward C. Jauch, MD MS FACEP22
30 Day Outcome of ICH30 Day Outcome of ICH
0
20
40
60
80
100
0 1 2 3 4 5 Dead
No. cases
Modified Oxford Handicap Scale
Edward C. Jauch, MD MS FACEP23
Clinical PresentationClinical Presentation
• Symptoms and signs– 82% change in mental status
– >75% hemiparesis/plegia
– 63% headache
– 22% vomiting
– 2/3 progression of symptoms, 1/3 maximal at onset
Edward C. Jauch, MD MS FACEP24
Clinical Presentation by LocationClinical Presentation by Location
• Lobar– Headache (headache location related to ICH site)– Motor, sensory deficit, or VF deficits (not all)
• Deep– Unilateral motor, sensory, VF loss– Aphasia (D) or neglect (ND)
• Cerebellum– Nausea, vomiting, ataxia, coma
• Pontine– Coma, quadriplegia, pinpoint pupils
Edward C. Jauch, MD MS FACEP25
ICH ProgressionICH Progression
• Symptoms often progress, associated with ICH growth– 26% with 33% or greater growth in 1 hour
– 12% with 33% or greater growth 1-20 hours
• This gives us a window of therapeutic opportunity
Edward C. Jauch, MD MS FACEP26
Prognostic InformationPrognostic Information
• Volume of hemorrhage
• Clinical presentation
• Intraventricular extension
(Kothari, Stroke)
Edward C. Jauch, MD MS FACEP27
Hematoma Volume CalculationHematoma Volume Calculation
• Formula for volume of an ellipsoid– 4/3Л (A/2)(B/2)(C/2)
– Simplified ABC/2
Edward C. Jauch, MD MS FACEP28
PrognosisPrognosis• Worse
– Volume > 60 cm3 and GCS < 9• 91% dead at 30 days
– Patients with volume over 30 cm3 only 1 / 71 independent at 30 days
– Intraventricular extension
• Better– Volume < 30 cm3 and GCS 9 or higher
• 19% dead at 30 days
(Broderick, Stroke)
Edward C. Jauch, MD MS FACEP29
PathophysiologyPathophysiology• Initial hemorrhage into surrounding
tissues causes:– Cytotoxic and vasogenic edema formation in
the perihematomal parenchyma– Neurotoxicity from released serum proteins
• Elevated intracranial pressure due to– Hematoma mass effect – Perihematomal edema – Intraventricular extension and hydrocephalus– Results in decreased perfusion
Current Recommendations for Current Recommendations for Management of Intracerebral Management of Intracerebral
HemorrhageHemorrhage
(Broderick, Stroke 1999)
•Emergency Medicine representationEmergency Medicine representation
•New guidelines due 2005New guidelines due 2005
Edward C. Jauch, MD MS FACEP30
Edward C. Jauch, MD MS FACEP31
Emergent EvaluationEmergent Evaluation• Baseline labs
– CBC, coags, electrolytes
• Neuroimaging – CT remains gold standard
• Identify ICH• Identify complications (hydrocephalus, herniation)
– MRI / MRA • Useful to evaluate for structural abnormalities• AVM, aneurysms
– Angiography• Rarely emergently indicated• Identify vascular issues preoperatively in occult ICH
Edward C. Jauch, MD MS FACEP32
Medical ManagementMedical Management• ABC’s• Blood pressure control• ICP management
– Hyperventilation– Osmotherapy– No role for glycerol, corticosteroids, hemodilution
• Other– Prevention of hyperthermia– Fluid management (CVP at 5-12 mm Hg)
• Modifications for age, comorbidities, size, severity, location • Seizure control• Find somebody to take the patient
Edward C. Jauch, MD MS FACEP33
Blood Pressure ManagementBlood Pressure Management• No definitive data (yet)• Hypertension very common
– MAP > 140 in 34%, > 120 in 78%– Many return to baseline over first 24 hours
ProspectiveRetrospective Case Series Results
Meyer et al. 1962
Lower BP good
Dandapani et al. 1995
Lower BP good
Qureshi et al. 1999
Lower BP bad
Brott T et al 1995
Hematoma enlargement not associated with degree of HTN
(Dr. Aninda Acharya, St.Louis University, Internet Stroke Center)(Dr. Aninda Acharya, St.Louis University, Internet Stroke Center)
Blood Pressure ManagementBlood Pressure Management
(Broderick, Stroke 1999) Edward C. Jauch, MD MS FACEP34
Edward C. Jauch, MD MS FACEP35
Management of Increased ICP Management of Increased ICP • Definition
– ICP > 20 mm Hg for > 5 mins
• Treatment goal– ICP < 20 mm Hg– CPP > 70 mm Hg
• Recommendations– ICP monitoring with GCS < 9
• Management– Osmotherapy– Hyperventilation– Ventricular drainage
Management of ICPManagement of ICP
(Broderick, Stroke 1999) Edward C. Jauch, MD MS FACEP36
Edward C. Jauch, MD MS FACEP37
Seizure TherapySeizure Therapy• 25% will have seizure• Much more common if lobar• Most in first 72 hours• Phenytoin is drug of choice• Does not convey life long epilepsy
Edward C. Jauch, MD MS FACEP38
What can be Fixed?What can be Fixed?
• Stop the bleeding– Until now no option
• Remove the blood– Multiple trials without clear impact
• Reduce the edema– No treatment yet
Edward C. Jauch, MD MS FACEP39
Surgical TreatmentSurgical Treatment
• Direct evacuation, endoscopic, stereotactic
Surgical Treatment Surgical Treatment RecommendationsRecommendations
(Broderick, Stroke 1999)
•7000 procedures a year in U.S. despite lack of data7000 procedures a year in U.S. despite lack of data•Largest surgical trial negative (in press)Largest surgical trial negative (in press)•MISTIE trial of stereotactic evacuation with tPAMISTIE trial of stereotactic evacuation with tPA
• (3/05) Surgery in 24 hrs, stable clot for 6 hrs(3/05) Surgery in 24 hrs, stable clot for 6 hrs
40
The Potential Future With Novo 7The Potential Future With Novo 7What Can We Learn From What Can We Learn From Acute Ischemic Stroke?Acute Ischemic Stroke?
41
Edward C. Jauch, MD MS FACEP42
Time Will Always Mean Brain!Time Will Always Mean Brain!
(Lancet (Lancet 2004; 363: 768–74)2004; 363: 768–74)
• Development: Protocol and pathway development• Detection: Early recognition• Dispatch: Early EMS activation• Delivery: Transport & management• Door: ED triage• Data: ED evaluation & management• Decision: Neurology input, therapy selection• Drug: Thrombolytic & future agents• Disposition: Admission or transfer
Same Chain: No Weak LinksSame Chain: No Weak Links
43
Edward C. Jauch, MD MS FACEP44
Emergent Triage and ED EvaluationEmergent Triage and ED EvaluationMust be a PriorityMust be a Priority
Edward C. Jauch, MD MS FACEP45
NINDS Recs: Same for ICHNINDS Recs: Same for ICH
• Door-to-MD: 10 minutes
• Door-to-Stroke 15 minutes Team notification:
• Door-to-CT scan: 25 minutes
• Door-to-Drug: 60 minutes (80% compliance)
• Door-to-Admission 3 hours
(NINDS Stroke Symposium 2003)(NINDS Stroke Symposium 2003)
Edward C. Jauch, MD MS FACEP46
There Will Be Major BarriersThere Will Be Major Barriers• EM education of disease and treatment• Timely radiology involvement• Access to neurologic expertise
– Neurology does not admit ICH– Neurosurgeons won’t rush in – EM will be point person like tPA
• Post treatment management– ICU beds– Complications likely to occur early
• Cost– Whose cost center– “Drip and ship” model
Edward C. Jauch, MD MS FACEP47
Who Cares for Patients with ICH?Who Cares for Patients with ICH?• Shortage of neurosurgeons• Shortage of neurocritical care • Neurologists not experienced with ICH• Emergency Medicine primarily focused on stabilization• Example – Cincinnati
– 30% neurosurgical shortage– Nonoperative ICH to neurology– Only 4 of 15 hospitals with neurosurgery coverage – Only 1 level 1 trauma largely due to neurosurgery
Edward C. Jauch, MD MS FACEP48
Potential Solution:Potential Solution:Utilize Primary Stroke CentersUtilize Primary Stroke Centers
• Patient care areas– Acute stroke teams
– Written care protocols
– EMS participation
– Emergency Department participation
– Stroke unit*
– Neurosurgical services**
• Support services– Organizational support– Stroke center director– Neuroimaging– Laboratory– Outcome & quality measures– CME
(Brain Attack Coalition, (Brain Attack Coalition, JAMAJAMA 2000) 2000)
• Secondary stroke center likely required for most ICH
Edward C. Jauch, MD MS FACEP49
ED Treatment and ED Treatment and Patient OutcomePatient Outcome
Edward C. Jauch, MD MS FACEP50
Questions??Questions?? www.ferne.orgwww.ferne.org
[email protected]@ferne.org
Edward Jauch, MD, MSEdward Jauch, MD, [email protected]
(513) 558-0474(513) 558-0474
ferne_acep_2005_jauch_ich_epipath_cd 04/20/23 12:56 AM